SE9901658D0 - New formulation - Google Patents

New formulation

Info

Publication number
SE9901658D0
SE9901658D0 SE9901658A SE9901658A SE9901658D0 SE 9901658 D0 SE9901658 D0 SE 9901658D0 SE 9901658 A SE9901658 A SE 9901658A SE 9901658 A SE9901658 A SE 9901658A SE 9901658 D0 SE9901658 D0 SE 9901658D0
Authority
SE
Sweden
Prior art keywords
new formulation
edisylate
methylthiazole
chloroethyl
physical
Prior art date
Application number
SE9901658A
Other languages
Swedish (sv)
Inventor
Karin Ellstroem
Ingrid Jaeppinen
Tomas Petersson-Norden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9901658A priority Critical patent/SE9901658D0/en
Publication of SE9901658D0 publication Critical patent/SE9901658D0/en
Priority to TNTNSN00094A priority patent/TNSN00094A1/en
Priority to PCT/SE2000/000876 priority patent/WO2000067753A1/en
Priority to AU47922/00A priority patent/AU4792200A/en
Priority to JP2000616779A priority patent/JP2002544164A/en
Priority to EP00930026A priority patent/EP1178798A1/en
Priority to ARP000102193A priority patent/AR023873A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate (generically known as clomethiazole edisylate) having improved antimicrobial properties in addition to physical, chemical and microbiological stability as well as biological compatibility.
SE9901658A 1999-05-06 1999-05-06 New formulation SE9901658D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9901658A SE9901658D0 (en) 1999-05-06 1999-05-06 New formulation
TNTNSN00094A TNSN00094A1 (en) 1999-05-06 2000-05-03 NEW COMPOSITION
PCT/SE2000/000876 WO2000067753A1 (en) 1999-05-06 2000-05-04 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
AU47922/00A AU4792200A (en) 1999-05-06 2000-05-04 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
JP2000616779A JP2002544164A (en) 1999-05-06 2000-05-04 Parenteral formulation of 5- (2-chloroethyl) -4-methylthiazole edisylate (clomethiazole edisylate)
EP00930026A EP1178798A1 (en) 1999-05-06 2000-05-04 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
ARP000102193A AR023873A1 (en) 1999-05-06 2000-05-05 FORMULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901658A SE9901658D0 (en) 1999-05-06 1999-05-06 New formulation

Publications (1)

Publication Number Publication Date
SE9901658D0 true SE9901658D0 (en) 1999-05-06

Family

ID=20415507

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901658A SE9901658D0 (en) 1999-05-06 1999-05-06 New formulation

Country Status (7)

Country Link
EP (1) EP1178798A1 (en)
JP (1) JP2002544164A (en)
AR (1) AR023873A1 (en)
AU (1) AU4792200A (en)
SE (1) SE9901658D0 (en)
TN (1) TNSN00094A1 (en)
WO (1) WO2000067753A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK733888A (en) * 1988-01-12 1989-07-13 Fujisawa Pharmaceutical Co stabilizer
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
SE8900564D0 (en) * 1989-02-17 1989-02-17 Astra Ab NOVEL MEDICINAL USE
SE9002659D0 (en) * 1990-08-15 1990-08-15 Astra Ab NEW PHARMACEUTICAL FORMULATIONS

Also Published As

Publication number Publication date
TNSN00094A1 (en) 2002-05-30
EP1178798A1 (en) 2002-02-13
AR023873A1 (en) 2002-09-04
AU4792200A (en) 2000-11-21
WO2000067753A1 (en) 2000-11-16
JP2002544164A (en) 2002-12-24

Similar Documents

Publication Publication Date Title
UY29041A1 (en) DERIVATIVES OF AMINO-PIPERIDINE, ITS PREPARATION AND ITS USE IN THERAPEUTICS
ECSP056111A (en) DERIVATIVES OF 2-ACILAMINO-4-FENILTIAZOL, ITS PREPARATION AND APPLICATION IN THERAPEUTICS
BR0116004A (en) Erythromycin 6-o-carbamoyl ketolide derivatives useful as antibacterials
DE60012188D1 (en) Fungicides
BR0115605A (en) Naphthalene derivatives
WO2005020894A3 (en) Rifamycin analogs and uses thereof
NO20062629L (en) Oxazole derivatives of tetracklines
BR0107815A (en) Amino derivatives of dihydro-1,3,5-triazine and their applications in therapy
UY29327A1 (en) DERIVATIVES OF N- (HETEROARIL) - 1 H- INDOL-2-CARBOXAMIDS, ITS PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
WO2006105889A3 (en) Synergistic fungicidal active substance combinations
BR0209149A (en) Phthalazinones
WO2005108565A3 (en) Modified xylanase, methods of making and use thereof
WO2006084688A8 (en) HIV protease inhibitors
RS51478B (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
PT1042319E (en) DI-HYDRO-BENZOFURANES
BR0213990A (en) Piperazine derivatives having sst1 antagonistic activity
WO2002050067A3 (en) Pharmaceutical heterocyclic compounds
BR0208566A (en) Beta Carboline Derivatives
BR0211903A (en) Isoxazolopyridinones
BR0115996A (en) Sulfamidothienopyrimidines
ATE449066T1 (en) BIGUANIDE DERIVATIVES
BR0113581A (en) Aryl piperazine derivatives and their use as psychotropic drugs
BR0316529A (en) Substituted pyridyloxyalkylamides and their use as fungicides
BR0108500A (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibitors
SE9901658D0 (en) New formulation